Differential effectiveness of dietary zinc supplementation with autism-related behaviours in Shank2 knockout mice
- PMID: 38853567
- PMCID: PMC11343228
- DOI: 10.1098/rstb.2023.0230
Differential effectiveness of dietary zinc supplementation with autism-related behaviours in Shank2 knockout mice
Abstract
The family of SHANK proteins have been shown to be critical in regulating glutamatergic synaptic structure, function and plasticity. SHANK variants are also prevalent in autism spectrum disorders (ASDs), where glutamatergic synaptopathology has been shown to occur in multiple ASD mouse models. Our previous work has shown that dietary zinc in Shank3-/- and Tbr1+/- ASD mouse models can reverse or prevent ASD behavioural and synaptic deficits. Here, we have examined whether dietary zinc can influence behavioural and synaptic function in Shank2-/- mice. Our data show that dietary zinc supplementation can reverse hyperactivity and social preference behaviour in Shank2-/- mice, but it does not alter deficits in working memory. Consistent with this, at the synaptic level, deficits in NMDA/AMPA receptor-mediated transmission are also not rescued by dietary zinc. In contrast to other ASD models examined, we observed that SHANK3 protein was highly expressed at the synapses of Shank2-/- mice and that dietary zinc returned these to wild-type levels. Overall, our data show that dietary zinc has differential effectiveness in altering ASD behaviours and synaptic function across ASD mouse models even within the Shank family. This article is part of a discussion meeting issue 'Long-term potentiation: 50 years on'.
Keywords: autism; shank; synapse; zinc.
Conflict of interest statement
We declare we have no competing interests.
Figures





Similar articles
-
Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice.Mol Brain. 2020 Aug 5;13(1):110. doi: 10.1186/s13041-020-00650-0. Mol Brain. 2020. PMID: 32758248 Free PMC article.
-
Dietary zinc supplementation rescues fear-based learning and synaptic function in the Tbr1+/- mouse model of autism spectrum disorders.Mol Autism. 2022 Mar 18;13(1):13. doi: 10.1186/s13229-022-00494-6. Mol Autism. 2022. PMID: 35303947 Free PMC article.
-
In vitro zinc supplementation alters synaptic deficits caused by autism spectrum disorder-associated Shank2 point mutations in hippocampal neurons.Mol Brain. 2021 Jun 24;14(1):95. doi: 10.1186/s13041-021-00809-3. Mol Brain. 2021. PMID: 34167580 Free PMC article.
-
The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders.Pharmaceuticals (Basel). 2022 Dec 20;16(1):1. doi: 10.3390/ph16010001. Pharmaceuticals (Basel). 2022. PMID: 36678498 Free PMC article. Review.
-
Modeling autism by SHANK gene mutations in mice.Neuron. 2013 Apr 10;78(1):8-27. doi: 10.1016/j.neuron.2013.03.016. Neuron. 2013. PMID: 23583105 Free PMC article. Review.
Cited by
-
Presymptomatic Biological, Structural, and Functional Diagnostic Biomarkers of Autism Spectrum Disorder.J Neurochem. 2025 May;169(5):e70088. doi: 10.1111/jnc.70088. J Neurochem. 2025. PMID: 40390287 Free PMC article.
-
Glioma-neuronal circuit remodeling induces regional immunosuppression.Nat Commun. 2025 May 22;16(1):4770. doi: 10.1038/s41467-025-60074-z. Nat Commun. 2025. PMID: 40404658 Free PMC article.
-
Long-term potentiation: 50 years on: past, present and future.Philos Trans R Soc Lond B Biol Sci. 2024 Jul 29;379(1906):20230218. doi: 10.1098/rstb.2023.0218. Epub 2024 Jun 10. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38853569 Free PMC article.
References
-
- Chilian B, Abdollahpour H, Bierhals T, Haltrich I, Fekete G, Nagel I, Rosenberger G, Kutsche K. 2013. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 84, 560–565. (10.1111/cge.12105) - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical